{"title":"MDFA-MLP: Multi-scale Dilated Fusion Attention and Ensemble Framework for Anticancer Peptide Prediction.","authors":"Binyu Li, Zhihua Huang, Yijie Ding, Xiaoyi Guo","doi":"10.2174/0113862073468655260630193344","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Experimental identification of anticancer peptides (ACPs) is timeconsuming and costly, which limits large-scale ACP discovery and screening. To address this challenge, we developed MDFA-MLP, a novel computational framework for ACP prediction that integrates multi-scale feature learning and ensemble classification strategies.</p><p><strong>Methods: </strong>The proposed framework combines physicochemical descriptors, including amino acid composition (AAC), dipeptide composition (DPC), composition-transition-distribution (CTD), and pseudo-amino acid composition (PseAAC), with ProtBERT-derived embeddings. A Multiscale Dilated Fusion Attention (MDFA) module was designed to capture sequence patterns at different scales and enhance feature fusion. An ensemble classifier consisting of a multilayer perceptron (MLP), support vector machine (SVM), and histogram-based gradient boosting (HGB) was employed to improve prediction robustness and stability.</p><p><strong>Results: </strong>The proposed model was evaluated on the AntiCP 2.0 dataset under the different negative-sample settings. On Dataset A, MDFA-MLP achieved an accuracy of 93.9%, sensitivity of 92.2%, specificity of 95.8%, and an MCC of 0.89. On the more challenging Dataset B, the model achieved an accuracy of 78.2%, sensitivity of 76.5%, specificity of 82.6%, and an MCC of 0.65. Comparative experiments demonstrated that MDFA-MLP achieved competitive and balanced performance across multiple evaluation metrics. Although the improvement over existing methods was moderate in some cases, the model maintained stable predictive performance under different negative-sample settings, indicating good robustness and generalization ability.</p><p><strong>Discussion: </strong>The results indicate that traditional sequence descriptors and deep protein language model embeddings provide complementary biological information. The MDFA module effectively enhances feature representation by integrating multi-scale sequence characteristics, while the ensemble strategy improves model robustness and generalization under varying data distributions.</p><p><strong>Conclusion: </strong>MDFA-MLP provides an effective and reliable framework for ACP prediction. By integrating handcrafted descriptors, protein language model representations, and ensemble learning, the proposed method can facilitate large-scale computational screening of candidate ACPs prior to experimental validation.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Combinatorial chemistry & high throughput screening","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113862073468655260630193344","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Experimental identification of anticancer peptides (ACPs) is timeconsuming and costly, which limits large-scale ACP discovery and screening. To address this challenge, we developed MDFA-MLP, a novel computational framework for ACP prediction that integrates multi-scale feature learning and ensemble classification strategies.
Methods: The proposed framework combines physicochemical descriptors, including amino acid composition (AAC), dipeptide composition (DPC), composition-transition-distribution (CTD), and pseudo-amino acid composition (PseAAC), with ProtBERT-derived embeddings. A Multiscale Dilated Fusion Attention (MDFA) module was designed to capture sequence patterns at different scales and enhance feature fusion. An ensemble classifier consisting of a multilayer perceptron (MLP), support vector machine (SVM), and histogram-based gradient boosting (HGB) was employed to improve prediction robustness and stability.
Results: The proposed model was evaluated on the AntiCP 2.0 dataset under the different negative-sample settings. On Dataset A, MDFA-MLP achieved an accuracy of 93.9%, sensitivity of 92.2%, specificity of 95.8%, and an MCC of 0.89. On the more challenging Dataset B, the model achieved an accuracy of 78.2%, sensitivity of 76.5%, specificity of 82.6%, and an MCC of 0.65. Comparative experiments demonstrated that MDFA-MLP achieved competitive and balanced performance across multiple evaluation metrics. Although the improvement over existing methods was moderate in some cases, the model maintained stable predictive performance under different negative-sample settings, indicating good robustness and generalization ability.
Discussion: The results indicate that traditional sequence descriptors and deep protein language model embeddings provide complementary biological information. The MDFA module effectively enhances feature representation by integrating multi-scale sequence characteristics, while the ensemble strategy improves model robustness and generalization under varying data distributions.
Conclusion: MDFA-MLP provides an effective and reliable framework for ACP prediction. By integrating handcrafted descriptors, protein language model representations, and ensemble learning, the proposed method can facilitate large-scale computational screening of candidate ACPs prior to experimental validation.
期刊介绍:
Combinatorial Chemistry & High Throughput Screening (CCHTS) publishes full length original research articles and reviews/mini-reviews dealing with various topics related to chemical biology (High Throughput Screening, Combinatorial Chemistry, Chemoinformatics, Laboratory Automation and Compound management) in advancing drug discovery research. Original research articles and reviews in the following areas are of special interest to the readers of this journal:
Target identification and validation
Assay design, development, miniaturization and comparison
High throughput/high content/in silico screening and associated technologies
Label-free detection technologies and applications
Stem cell technologies
Biomarkers
ADMET/PK/PD methodologies and screening
Probe discovery and development, hit to lead optimization
Combinatorial chemistry (e.g. small molecules, peptide, nucleic acid or phage display libraries)
Chemical library design and chemical diversity
Chemo/bio-informatics, data mining
Compound management
Pharmacognosy
Natural Products Research (Chemistry, Biology and Pharmacology of Natural Products)
Natural Product Analytical Studies
Bipharmaceutical studies of Natural products
Drug repurposing
Data management and statistical analysis
Laboratory automation, robotics, microfluidics, signal detection technologies
Current & Future Institutional Research Profile
Technology transfer, legal and licensing issues
Patents.